Opus Genetics, Inc.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-8.1M | $-65.5M | $-16.5M | $-17.5M | $-7.4M | $-8.2M | $-35.1M | $-7.5M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | $14.0K | $13.0K | $13.0K | $13.0K | $14.0K | $13.0K | $10.0K | $0 |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $1.4M | $1.5M | $774.0K | $816.0K | $896.0K | $913.0K | $795.0K | $776.0K |
| Net Cash from Operating Activities | $-12.0M | $-12.7M | $-9.8M | $-6.2M | $-10.3M | $-9.0M | $-7.4M | $-5.1M |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $0 | $0 | $0 | $0 | $0 | $0 | $1.2M | $0 |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $40.9M | $27.6M | $24.1M | $4.5M | $906.0K | $20.5M | $-83.0K | $353.0K |
| Net Change in Cash | $29.0M | $14.9M | — | — | $-9.4M | $11.5M | — | — |
| Free Cash Flow | — | — | — | — | — | — | — | — |